BACKGROUND: Vitamin D deficiency has a pathogenetic and prognostic role in coronary artery disease. Moreover, Vitamin D has a key role in pain modulation and transmission. Diabetic patients have a high risk of silent myocardial ischemia (SMI), due to diabetic neuropathy. We aimed to evaluate the correlation between SMI and Vitamin D serum levels in a population of type 2 diabetic patients and to assess whether SMI patients had a worse survival than their symptomatic counterpart.METHODS: In this retrospective, cross-sectional, observational study, we enrolled 253 patients admitted in Policlinico of Modena Hospital and compared them with 50 healthy volunteers. We divided the 253 patients into three sub-groups: symptomatic MI group (125, 32.4%); SMI (78, 25.7%), and no-MI one (50, 41.9%). The entire population had a 25-hydroxyvitamin D (25(OH)D) measurement. RESULTS: 25(OH)D levels (nmol/l) were lower in SMI group (34.9 ± 5.8) respect to symptomatic MI (49.6 ± 6.1; p = 0.01); no MI (53.1 ± 6.2; p = 0.001) and control group (62.1 ± 6.7; p = 0.0001). 25(OH)D level was the only independent variable able to influence the development of SMI in diabetic patients, with an inverted odd-ratio of 1.11 (p = 0.01). Symptomatic MI group had better survival than SMI one (6-year survival rate: 83 vs. 69%; p = 0.01)CONCLUSIONS: Type 2 diabetic with SMI had a higher mortality risk and showed lower 25(OH)D levels than the symptomatic group. This suggests the crucial vitamin D role in the pathogenesis of SMI.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.